News

As leaders look to design the laboratory of the future, the ones that enable agility, flexibility and sustainability will be ...
LMO2 is an intrinsically disordered transcription factor activated in T cell leukaemia that is difficult to target. It forms part of a multiprotein complex that has bipartite DNA binding through ...